Oct. 28, 2024 — As cannabis is legalized and is more accessible in various forms across the country, there is increasing concern among health care providers about potential impact on children ...

When: Martha is now streaming on Netflix. What to know: The latest in a recent spate of celebrity-focused documentaries covers Martha Stewart, the lifestyle guru and self-made billionaire who ...

Every season of Saturday Night Live introduces the world to a slew of viral cultural moments, but the show is celebrating a huge milestone this year: its 50th season. The live sketch-comedy show ...

The health system in Israel is mainly public, and every Israeli citizen has the right to hold basic health insurance. However, many choose supplemental health insurance, which can cover additional ...

IT certifications can verify your knowledge in various skillsets, boost your pay, and set you apart from other entry-level candidates. Here are the entry-level certs worth pursuing. Certifications ...

Here's a running list of movie-inspired clothing, beauty products, homeware, games and collectibles from brands like Crocs, Béis, Gap, H&M, Voluspa, Lego, Mattel and Conair. By Erin Lassner ...

Health insurance costs $584 per month on average for a 40-year-old with a Silver plan. That's 4% higher than last year. In 2024, a Silver health plan costs $584 per month on average for a 40-year-old.

Novartis posted third-quarter results that beat analysts' estimates and raised its full-year outlook, buoyed by strong sales of drugs like breast-cancer treatment Kisqali. The Swiss pharmaceutical ...

Recent actions by state and federal lawmakers are trending toward increased regulation and oversight of uses of AI in health care. From patient communications to medical necessity determinations ...

Please see our original notice from October 15, 2024 for details on what to expect during and after the forum. We appreciate your patience and look forward to hearing your feedback.

This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali) as a Category 1 preferred CDK4/6 inhibitor (CDK4/6i) ...